Pure Global
NCT05565612

Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome

Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome
Laboratorio Industrial de Herbodietetica Aplicada S.L·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
IBS - Irritable Bowel Syndrome
Drug/Device/Intervention
Normodigest Classic
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Laboratorio Industrial de Herbodietetica Aplicada S.L
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2022
End date
Jun 01, 2023
Enrollment
25 participants
Primary outcome

Change from baseline on IBS-SSS (Irritable Bowel Syndrome-Severity Scoring System) scale at 4, 8 and 12 weeks

Summary

The clinical trial has a randomized, double-blind and placebo-controlled design, in which the
 effect of a probiotic mix wants to be evaluated, with a treatment of 12 weeks, in the
 evolution of the symptoms of Irritable Bowel Syndrome.
 
 The 12 weeks of the treatment are structured in four in-person visits: Visit 1 (initial; week
 0), Visit 2 (halfway; week 4), Visit 3 (halfway; week 8) and Visit 4 (final; week 12).

ICD-10 classifications
Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05565612
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05565612 through Pure Global AI's free database. This phase not specified trial is sponsored by Laboratorio Industrial de Herbodietetica Aplicada S.L and is currently Not yet recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.